- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | RBC Capital reiterates Outperform rating on EyePoint stock amid recent decline | ||
| Fr | TD Cowen raises Bloom Energy stock price target to $160 on data center demand | ||
| Fr | Novo Nordisk stock price target lowered to $45 by BMO Capital | ||
| Fr | FirstService stock price target lowered to $202 by BMO Capital | ||
| Fr | Boston Scientific stock holds Outperform rating at Evercore despite EP miss | ||
| Fr | Goldman Sachs downgrades Atlas Copco stock to Neutral on FX headwinds | ||
| Fr | Coherent stock price target raised to $245 by JPMorgan on AI wins | ||
| Fr | Mitsubishi Electric Q3 FY26 slides: Record revenue despite restructuring costs | ||
| Fr | Mitsubishi Motors Q3 FY2025 slides: Profit plunges 70% despite new model momentum | ||
| Fr | Mitsui Q1-3 FY2026 slides: COCF forecast raised despite profit challenges | ||
| Fr | Luxembourg-based Nexa Resources achieves 2025 mining guidance | ||
| Fr | MIXI Q3 FY2026 slides: Sports segment doubles, overall revenue up 18% | ||
| Fr | Mitsui Fudosan Q3 FY2025 slides: profit jumps 52.7%, full-year forecasts raised | ||
| Fr | JR East Q3 2026 slides: revenue growth across segments, operating income dips on higher costs | ||
| Fr | Alphabet stock price target raised to $400 from $343 at BMO Capital | ||
| Fr | Eli Lilly stock price target raised to $1,300 by BMO Capital | ||
| Fr | Moelis stock price target raised to $78 from $75 at BMO Capital | ||
| Fr | Crown Castle stock price target lowered to $91 by BMO Capital | ||
| Fr | RBC Capital sees defense tech stock pullback as buying opportunity | ||
| Fr | Eli Lilly stock price target raised to $1,300 by JPMorgan on obesity drug momentum | ||
| Fr | Alphabet stock price target raised to $395 by JPMorgan on strong growth | ||
| Fr | BMO Capital lowers PTC stock price target to $189 on 1Q results | ||
| Fr | Equifax stock price target lowered to $222 by RBC Capital on market concerns | ||
| Fr | FDA removes limitations on Yescarta for rare brain lymphoma | ||
| Fr | Upexi announces $7.4 million registered direct offering at $1.17 per share |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.